Condition
Immune Dysregulation clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Immune Dysregulation clinical trials that are recruiting, at sites in 2 countries (most in United States (3), Belgium (1)). By phase: Phase 4 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Immune Dysregulation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Toxin exposure and immune factors in B-cell non-Hodgkin lymphoma | — | Bethesda, Maryland and 2 other locations | Recruiting | Jun 17, 2026 |
| Immune cells in lung disease and how they could guide immunotherapy | — | Brussels | Recruiting | Feb 3, 2026 |
| Reduced-intensity hematopoietic stem cell transplant for CVID and other primary immune regulatory disorders | Phase 2 | Pittsburgh, Pennsylvania | Recruiting | Dec 16, 2025 |
| Using metformin to improve immune function in people with a history of injection drug use | Phase 4 | Birmingham, Alabama | Recruiting | Feb 17, 2025 |
All recruiting trials (4)
-
Toxin exposure and immune factors in B-cell non-Hodgkin lymphoma
This study tests how toxin exposure, genetics, and immune issues relate to B-cell non-Hodgkin lymphoma in active-duty service members and other Military Health System beneficiaries.
-
Immune cells in lung disease and how they could guide immunotherapy
This project sees if immune cell profiling from blood can explain why people with lung cancer, sarcoidosis, or COPD respond differently to immunotherapy or develop chronic lung inflammation.
-
Reduced-intensity hematopoietic stem cell transplant for CVID and other primary immune regulatory disorders
This will try a reduced-intensity hematopoietic stem cell transplant with low-dose total body irradiation to correct or improve severe CVID and related primary immune regulatory disorders in people aged 5 to 40.
-
Using metformin to improve immune function in people with a history of injection drug use
This study is testing if the diabetes drug metformin can help improve the immune system and reduce inflammation in people aged 18-64 who have a history of using injection drugs.
Related topics
Quick answers
How many Immune Dysregulation clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.